• linkedin
  • Increase Font
  • Sharebar

    Activists: drugmakers, distributors liable for opioids abuse

    Soon after President Donald Trump announced declared the opioid abuse crisis a “public health emergency,” shareholder activist groups said they aim to hold drug manufacturers and distributors liable for their part in the crisis.

    Leaders of a 30-fund group that includes state pension officials and religious and labor organizations said they are filing shareholder resolutions at 10 companies, including distributors AmerisourceBergen Corp. and Cardinal Health, along with manufacturers such as Johnson & Johnson and Insys Therapeutics, Reuters reported.

    Federal prosecutors also charged John Kapoor, the founder of Insys, with participating in a scheme to bribe doctors to prescribe a particularly potent opioid. A lawyer for Kapoor said in a statement that Kapoor is innocent and will fight the charges, Reuters reported.

    The shareholder activists seek corporate-governance reforms including allowing more grounds to claw back pay from executives who inappropriately promote opioid painkillers and creating independent board chairs to provide better oversight. They are also urging independent directors to review and report on how the boards are managing the legal, financial and reputational risks their enterprises face from their involvement with opioids.

    “We believe these companies have played an important role in this epidemic,” Donna Meyer, director of shareholder advocacy for Mercy Investment Services, an investment fund for Roman Catholic nuns that is leading the push against drugmakers and distributors, told Reuters. The UAW Retiree Medical Benefits Trust, which oversees benefits for about 700,000 retirees of the United Auto Workers, is another group involved in the campaign.

    Late last week, Trump declared the opioid crisis a “public national health emergency”, which does not automatically direct additional federal funding to combat the crisis, CNN reported.

    However, federal agencies will be directed to devote more grant money already in their budget to the problem and take "action to overcome bureaucratic delays and inefficiencies in the hiring process," according to a fact sheet on Trump's order.

    Meanwhile, Cardinal Health will face a resolution calling for an independent board chair in order to improve oversight at its annual meeting on November 8.

    “These considerations are especially critical at Cardinal given the potential reputational, legal and regulatory risks Cardinal faces over its role in the nation’s opioid epidemic, including its history of compliance challenges concerning the distribution of controlled substances,” the resolution’s sponsors, including the International Brotherhood of Teamsters, said in a supporting statement.

    The statement cited Cardinal’s payment of tens of millions of dollar to settle various federal and state charges related to opioids, Reuters reported.

    Meanwhile, AmerisourceBergen “welcomes a productive dialogue with all shareholders,” Spokeswoman Keri Mattox said. “The issue of opioid abuse is a complex one that spans the full healthcare spectrum, including manufacturers, wholesalers, insurers, prescribers, pharmacists and regulatory and enforcement agencies.”

    1 Comment

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • [email protected]
      Activists seem to think everybody is to blame except the "victim". In my years as a retail pharmacist I have yet to see a manufacturer or wholesaler/distributor write a single prescription for a narcotic. I have always lived by the adage that I do not live in another person's body so I do not have any perception of their pain and what it takes to control it. I do know that most prescribers are limiting the quantities they prescribe but when I see an arrest of a person locally that would travel to a particular city and return with thousands of oxycodone tablets or even legitimate pain control physicians that routinely prescribe 100's of doses per month I have to wonder where the doses are coming from or where are they all going? They only reason the distributors and pharmacies are being sued is they have the deepest pockets. If you go after a physician's assets you may get a few million of a retirement fund. It's more cost effective to sue the dispensers..... those who do not write a single prescription.